- Companies
- Colgate-Palmolive (India)
Colgate-Palmolive (India) Valuation Multiples
Colgate-Palmolive (India) is valued at $4.8B as of November 2026, a 6.9x revenue multiple. In the last 12 months, Colgate-Palmolive (India) revenue was $671M and Colgate-Palmolive (India) EBITDA was $202M.
Colgate-Palmolive (India) Overview
About Colgate-Palmolive (India)
Colgate-Palmolive (India) Ltd is a personal care and oral care company. The company operates under a single reportable segment, Personal Care (including Oral Care), which includes soaps, cosmetics, toilet preparations, and other products. The company manufactures oral-care products, such as toothpaste, toothbrushes, whitening products, and mouthwash solutions. Personal care products include body wash, hand soaps, skincare, and hair care. Geographically, the company generates a majority of its revenue within India and the rest from overseas markets.
Founded
1937
HQ
Employees
2.2K
Website
Sectors
Financials (LTM)
EV
$4.6B
Valuation Multiples
Start free trialColgate-Palmolive (India) Financials
Colgate-Palmolive (India) reported last 12-month revenue of $671M and EBITDA of $202M.
In the same LTM period, Colgate-Palmolive (India) generated $467M in gross profit, $202M in EBITDA, and $145M in net income.
Revenue (LTM)
Colgate-Palmolive (India) P&L
In the most recent fiscal year, Colgate-Palmolive (India) reported revenue of $632M and EBITDA of $195M.
Colgate-Palmolive (India) is profitable as of last fiscal year, with gross margin of 64%, EBITDA margin of 31%, and net margin of 22%.
Financial data powered by Morningstar, Inc.
Colgate-Palmolive (India) Stock Performance
Colgate-Palmolive (India) has current market cap of $4.8B, and enterprise value of $4.6B.
Market Cap Evolution
Colgate-Palmolive (India)'s stock price is $17.51.
Colgate-Palmolive (India) share price increased by 4.5% in the last 30 days, and decreased by 27.8% in the last year.
Colgate-Palmolive (India) has an EPS (earnings per share) of $0.51.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4.6B | $4.8B | 1.8% | 4.5% | -12.0% | -27.8% | $0.51 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialColgate-Palmolive (India) Valuation Multiples
Colgate-Palmolive (India) trades at 6.9x EV/Revenue multiple, and 22.8x EV/EBITDA.
EV / Revenue (LTM)
Colgate-Palmolive (India) Financial Valuation Multiples
As of November 5, 2026, Colgate-Palmolive (India) has market cap of $4.8B and EV of $4.6B.
Colgate-Palmolive (India) has a P/E ratio of 32.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Colgate-Palmolive (India) Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Colgate-Palmolive (India) Margins & Growth Rates
Colgate-Palmolive (India) grew revenue by 10% and EBITDA by 5% in the last fiscal year.
In the most recent fiscal year, Colgate-Palmolive (India) reported gross margin of 64%, EBITDA margin of 31%, and net margin of 22%.
Colgate-Palmolive (India) Margins
Colgate-Palmolive (India) Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Colgate-Palmolive (India) Operational KPIs
Colgate-Palmolive (India)'s revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Colgate-Palmolive (India)'s Rule of 40 is 39% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Colgate-Palmolive (India)'s Rule of X is 52% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Colgate-Palmolive (India) Competitors
Colgate-Palmolive (India) competitors include Cupid, GSK India, Yakult Honsha, Inter Parfums, Rohto Pharmaceutical, Fielmann Group, AmorePacific, Interparfums, Lion Corp. and Hengan Group.
Most Colgate-Palmolive (India) public comparables operate across Health & Beauty.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $37M | $14M | 128.6x | - | 342.0x | - | |||
| $402M | $150M | 10.7x | 10.0x | 28.7x | 28.9x | |||
| $3.1B | $574M | 1.5x | 1.5x | 8.2x | 10.1x | |||
| $1.5B | $300M | 2.8x | 2.8x | 13.8x | 14.7x | |||
| $2.2B | $407M | 1.8x | 1.7x | 9.5x | 9.9x | |||
| $2.7B | $603M | 1.5x | 1.4x | 6.8x | 6.3x | |||
| $3.2B | $463M | 1.7x | 1.5x | 11.4x | 10.1x | |||
| $1B | $222M | 3.4x | 3.4x | 15.3x | 16.3x | |||
This data is available for Pro users. Sign up to see all Colgate-Palmolive (India) competitors and their valuation data. Start Free Trial | ||||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Colgate-Palmolive (India)
| Who are competitors of Colgate-Palmolive (India)? | Colgate-Palmolive (India) main competitors include Cupid, GSK India, Yakult Honsha, Inter Parfums, Rohto Pharmaceutical, Fielmann Group, AmorePacific, Interparfums, Lion Corp., Hengan Group. |
See public comps similar to Colgate-Palmolive (India)
Lists including Colgate-Palmolive (India)
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




